Altimmune, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Altimmune, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Altimmune, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 10.3 %, a 4.98% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 10.3 -0.54 -4.98% Sep 30, 2024
Q2 2024 10.3 -0.29 -2.74% Jun 30, 2024
Q1 2024 9.3 -0.88 -8.65% Mar 31, 2024
Q4 2023 9.95 -0.19 -1.87% Dec 31, 2023
Q3 2023 10.8 +1.12 +11.5% Sep 30, 2023
Q2 2023 10.6 -0.02 -0.19% Jun 30, 2023
Q1 2023 10.2 +0.1 +0.99% Mar 31, 2023
Q4 2022 10.1 +1.08 +11.9% Dec 31, 2022
Q3 2022 9.72 +0.98 +11.2% Sep 30, 2022
Q2 2022 10.6 +1.15 +12.2% Jun 30, 2022
Q1 2022 10.1 -2.34 -18.8% Mar 31, 2022
Q4 2021 9.06 -7.01 -43.6% Dec 31, 2021
Q3 2021 8.74 -12.3 -58.5% Sep 30, 2021
Q2 2021 9.45 -14.1 -59.8% Jun 30, 2021
Q1 2021 12.4 -5 -28.7% Mar 31, 2021
Q4 2020 16.1 +3.07 +23.6% Dec 31, 2020
Q3 2020 21.1 +9.21 +77.8% Sep 30, 2020
Q2 2020 23.5 +8.09 +52.4% Jun 30, 2020
Q1 2020 17.4 -5.21 -23% Mar 31, 2020
Q4 2019 13 -17.3 -57.1% Dec 31, 2019
Q3 2019 11.8 -25.3 -68.1% Sep 30, 2019
Q2 2019 15.4 -22.1 -58.9% Jun 30, 2019
Q1 2019 22.6 -7.09 -23.8% Mar 31, 2019
Q4 2018 30.3 +4.85 +19.1% Dec 31, 2018
Q3 2018 37.1 +15.1 +68.4% Sep 30, 2018
Q2 2018 37.5 +27.4 +268% Jun 30, 2018
Q1 2018 29.7 +22.2 +295% Mar 31, 2018
Q4 2017 25.4 +17.2 +209% Dec 31, 2017
Q3 2017 22 +15.6 +241% Sep 30, 2017
Q2 2017 10.2 -2.94 -22.4% Jun 30, 2017
Q1 2017 7.53 -7.06 -48.4% Mar 31, 2017
Q4 2016 8.22 -8.07 -49.5% Dec 31, 2016
Q3 2016 6.45 -16 -71.2% Sep 30, 2016
Q2 2016 13.1 -11.8 -47.4% Jun 30, 2016
Q1 2016 14.6 -13.3 -47.6% Mar 31, 2016
Q4 2015 16.3 -18.5 -53.2% Dec 31, 2015
Q3 2015 22.4 -34.6 -60.7% Sep 30, 2015
Q2 2015 25 -52.8 -67.9% Jun 30, 2015
Q1 2015 27.9 -62.8 -69.3% Mar 31, 2015
Q4 2014 34.8 -66.6 -65.7% Dec 31, 2014
Q3 2014 57 -37.6 -39.8% Sep 30, 2014
Q2 2014 77.8 -17.8 -18.6% Jun 30, 2014
Q1 2014 90.7 -2 -2.16% Mar 31, 2014
Q4 2013 101 +17.7 +21.1% Dec 31, 2013
Q3 2013 94.7 +24.6 +35.1% Sep 30, 2013
Q2 2013 95.6 +34.5 +56.4% Jun 30, 2013
Q1 2013 92.7 +28.7 +44.8% Mar 31, 2013
Q4 2012 83.8 Dec 31, 2012
Q3 2012 70.1 Sep 30, 2012
Q2 2012 61.2 Jun 30, 2012
Q1 2012 64 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.